An absolute pleasure to be part of the European Congress of Radiology in Vienna! The ProCAncer-I project team presented the special challenges of the project at a special session. Really good to connect with everyone again face to face!
The 1st ProCAncer- I Dissemination Event, presenting the vision of the project, took place in Vienna on the 15th of July 2022 as a special session during the ECR 2022. At the presentation and discussion panel participated  members both of the ProCAncer -I project and the FUTURE – AI initiative: Manolis Tsiknakis, Nickolas Papanikolaou, Daniele Regge, Luis Marti-Bonmati, Hariet C. Thoeny, Mustafa Nasuh Özmen, Emanuele Neri, Kostas Marias and Ioannis Seimenis.

The session with the title “Building bridges. From radiomics /AI research to clinical practice: The ProCAncer – I vision” was an opportunity for the researchers to engage with different stakeholders as well as the general public since the attendees of the ECR came from all areas of the radiology arena: radiology professionals, radiographers, physicists, medical imaging in general and industry representatives.

Highlights

ProCAncer-I at the EMUC24 in Lisbon

ProCAncer-I at the EMUC24 in Lisbon

The progress of major trials, the advent of artificial intelligence (AI), and interdisciplinary best practices will comprise the scientific programme of the 16th European Multidisciplinary Congress on Urological Cancers (EMUC24), which will take place from 7 to 10...

Third Dissemination Event of the ProCAncer-I Project in Athens

Third Dissemination Event of the ProCAncer-I Project in Athens

ProCAncer-I organised the 3rd Dissemination Event of the project at the 21st IEEE International Symposium on Biomedical Imaging, held in Athens, Greece, May 27-30, 2024. During the symposium, ProCAncer-I organised the Workshop “Integrating imaging Data and AI models...

AI in PCa imaging : The current status and future perspectives

AI in PCa imaging : The current status and future perspectives

Ιn recent years, magnetic resonance imaging (MRI) has transformed the prostate cancer (PCa) diagnostic pathway, based on the evidence of multiple high-level evidence studies (refs 4M, MRI first, and PROMIS). Taken together, the evidence indicates that prostate MRI...

Twitter feed is not available at the moment.

Stay in touch!